ProKidney Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-35.3	-35.47	-108.03	-55.15	-26.75
Depreciation & Amortization	4.12	3.85	3.04	1.98	0.96
Share-Based Compensation	25.51	30.85	74.47	0.7	0.73
Other Operating Activities	-93.06	-89.3	-46.56	2.16	-0.13
Operating Cash Flow	-98.72	-90.07	-77.09	-50.3	-25.18
Capital Expenditures	-34.17	-34.2	-1.85	-5.19	-5.46
Acquisitions	0	0	0.11	0	0
Change in Investments	-44.8	-295.79	0	0	0
Investing Cash Flow	-78.97	-329.98	-1.74	-5.19	-5.46
Share Issuance / Repurchase	-9.5	-9.5	548.55	71.5	20
Debt Issued / Paid	-0.05	-0.05	-0.03	-0.03	-0.01
Financing Cash Flow	-9.55	-9.55	548.52	71.47	19.99
Net Cash Flow	-187.25	-429.6	469.69	15.98	-10.65
Free Cash Flow	-132.89	-124.27	-78.94	-55.49	-30.64
Free Cash Flow Per Share	-2.18	-2.01	-1.28	-0.37	-0.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).